Clinical trial
Study to Determine the Effectiveness of the Probiotic E. Coli Strain M17 in…
NCT00194922 · Weill Medical College of Cornell University, Other · Completed
Key facts
| NCT number | NCT00194922 |
|---|---|
| Title | Study to Determine the Effectiveness of the Probiotic E. Coli Strain M17 in Treating Irritable Bowel Syndrome (IBS) |
| Official title | A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study of the Tolerance and Efficacy of the Probiotic E. Coli Strain M17 on Symptoms and Quality of Life in Individuals With Irritable Bowel Syndrome (IBS) |
| Lead sponsor | Weill Medical College of Cornell University, Other |
| Collaborators | BioBalance Corporation Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Irritable Bowel Syndrome (IBS) |
| Intervention type | Dietary Supplement |
| Interventions | E. Coli Strain M17 Probiotic |
| Enrollment | 35 |
| Start date | Aug 1, 2004 |
| Primary completion | Nov 1, 2006 |
| Completion | Nov 1, 2006 |
| First posted | Sep 19, 2005 |
| Last update posted | Apr 4, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: